Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 9,176 shares at $50.00 ($468K) on 2026-06-04, disclosed to the SEC on 2026-06-08.
Scheduled sale ($468k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 3,471 | $174K | 37.1% |
| 2 | $51.59 | 5,705 | $294K | 62.9% |
| Total | $50.99 avg | 9,176 | $468K | 100% |
| Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |
| MRNA | SELL | 2024-12-02 | $121K | — | Filing → |